Commercial play, pre-Broadway tryout (Boston)
$15,000
$25,000 (units of $25,000)
April 3 to April 18, 2026, 24 performances, 736 seats
Huntington Theatre (Boston)
Accredited Investors Only
$1,598,884
$250,000
Pre-production, world premiere scheduled
This opportunity is to invest in a new play, from a writer with a dedicated pre-Broadway following and a reputation for thought provoking work. The production is being mounted by a team of experienced Broadway producers, presenting a chance to participate in a high-risk, high-reward asset class that is traditionally inaccessible to most investors.Â
We are intrigued by the combination of a distinctive artistic voice with a commercially experienced production team. The structure of the offering allows for direct participation in the potential financial success of a Broadway show. However, the commercial prospects of a serious play on Broadway are always a key consideration, as is the substantial upfront capitalization required.Â
We’d want to dig further into:Â
Investing in a pre-Broadway show is a high-risk venture. The initial investment is significant, and there is no guarantee of a return. The success of a show is dependent on a wide range of factors, including critical reviews, audience reception, and the overall health of the market. This is an illiquid investment, with no secondary market. For those with a passion for theatre and a high tolerance for risk, this could be a compelling opportunity. To learn more and to access the full offering memorandum, please register for a free membership with Rainmakers Collective.Â
This overview is for informational purposes only and is not an offer to sell or a solicitation of an offer to buy any security.
Â